Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 2/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | EPHX1 | P07099 | 3/20 | 0.34 |
| ▸ | NAAA | Q02083 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 2/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | MMP2 | P08253 | 2/20 | 0.30 |
| ▸ | MMP9 | P14780 | 2/20 | 0.30 |
| ▸ | ANPEP | P15144 | 2/20 | 0.30 |
| ▸ | LTA4H | P09960 | 1/20 | 0.30 |
| ▸ | LAP3 | P28838 | 1/20 | 0.30 |
| ▸ | NPEPPS | P55786 | 1/20 | 0.30 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.30 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6522464 | 0.98 | CYP19A1 (0.38) | CYP19A1L3MBTL1EPHX1NAAAHTT | |
| SCHEMBL22615828 | 0.76 | CYP19A1 (0.44) | CYP19A1L3MBTL1EPHX1NAAAHTT | |
| SCHEMBL6514845 | 0.74 | SMN1; SMN2 (0.33) | — | |
| SCHEMBL8984845 | 0.73 | CYP19A1 (0.53) | CYP19A1L3MBTL1EPHX1NAAAHTT | |
| SCHEMBL6520398 | 0.73 | CYP19A1 (0.46) | CYP19A1L3MBTL1EPHX1NAAAHTT | |
| SCHEMBL6520408 | 0.73 | CYP19A1 (0.46) | CYP19A1L3MBTL1EPHX1NAAAHTT | |
| SCHEMBL6518789 | 0.71 | ALDH1A1 (0.32) | GAA | |
| SCHEMBL11941710 | 0.71 | CYP19A1 (0.47) | CYP19A1L3MBTL1EPHX1NAAAHTT | |
| SCHEMBL6522160 | 0.71 | CYP19A1 (0.44) | CYP19A1L3MBTL1EPHX1NAAAHTT | |
| SCHEMBL6522152 | 0.71 | CYP19A1 (0.44) | CYP19A1L3MBTL1EPHX1NAAAHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6958366-B2 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2005-10-25 | — | — | US | disclosed |
| US-20030118544-A1 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2003-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030118544-A1 | Antifouling coating composition and novel resin | COL1A1, GLRA1, COL2A1 | CYP19A1 2315/4885L3MBTL1 1615/4885EPHX1 558/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.